Dose Insertion

TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in Oncology

A dose insertion design for phase I/II clinical trials in oncology based on both efficacy and toxicity outcomes.